Targeting duplex DNA with DNA‐PNA chimeras? Physico‐chemical characterization of a triplex DNA‐PNA/DNA/DNA

Targeting double-stranded DNA with homopyrimidine PNAs results in strand displacement complexes PNA/DNA/PNA rather than PNA/DNA/DNA triplex structures. Not much is known about the binding properties of DNA-PNA chimeras. A 16-mer 5'-DNA-3'-p-(N)PNA(C) has been investigated for its ability to hybridize a complementary duplex DNA by DSC, CD, and molecular modeling studies. The obtained results showed the formation of a triplex structure having similar, if not slightly higher, stability compared to the same all-DNA complex.     

Composites of peptide nucleic acids with titanium dioxide nanoparticles. II. Dissociation of DNA/PNA duplexes within TiO2 · polylysine · DNA/PNA nanocomposites and in solution. Effect of polylysine

When creating effective drugs, it is important not only to transport them into cells, but also allow them to be released from the “transporter” after the delivery. It was shown that the dissociation of peptide nucleic acids (PNA) from TiO₂ · PL · DNA/PNA nanocomposites occurred according to a typical thermal denaturation, and polylysine (PL) in the nanocomposite has almost no effect on the dissociation. These data suggest that the immobilization of PNA in the TiO₂ · PL · DNA/PNA nanocomposite is reversible and PNA can be easily released from TiO₂ carrier into solution. In contrast to that, the dissociation of DNA/DNA and DNA/PNA duplexes in physiological solution in the presence of PL was not observed. PL in solution dramatically influences the dependence of the optical density on temperature and time for DNA/DNA duplexes and to a lesser degree for DNA/PNA duplexes. It has been assumed that PL and DNA/DNA duplexes in physiological solutions form triple polycomplexes (DNA/DNA · PL) _m , which can aggregate and precipitate. PL in solution can also interact with DNA/PNA duplexes to form monocomplexes PL · (DNA/PNA) _n consisting of one PL chain and one or more (n) DNA/PNA duplexes. Although these monocomplexes do not precipitate, the dissociation of DNA/PNA duplexes from them is complicated.     

PNA简介

多肽核酸寡聚物(Peptide Nucleic Acids)简称PNA寡聚物。此类分子是如此新奇,以致于它们正在改写自然界的性质。 与DNA和RNA相似,PNA也在其4种碱基:腺嘌呤、鸟嘌呤,胞嘧啶和胸腺嘧啶的顺序中携带信息。然而,在PNA中,这些密码的携带是与一种完全不同的骨架(一种类似于多肽中发现的多胺体骨架)联系在一起。PNA寡聚物比其天然副本更为稳定,且能以更高的     

基于PNA的最大独立集问题的DNA计算模型

肤核酸(Peptide Nucleic Acid)是人工合成的拔酸(DNA)的类似物.PNA能够特异地、稳定地与DNA杂交以及其独特的性质,使得PNA广泛应用在分子生物学中.本文提出了一种基于PNA的最大独立集问题的DNA计算模型,利用单链PNA被逐步褪火到单链DNA分子上,解决了一个最大独立集问题的实例.该模型的解空间只有一种类型的DNA分子,计算经m步生物操作产生问题的解(其中m=|E(G)|),最后利用鞭子PCR(whiplash PCR)原理以及凝胶电泳读解.     

Foldamers derived from nucleoside beta-amino acids: PNA Or DNA? Can we have both in one place?

The synthesis of a modified thymidine (nucleoside beta-amino acid) monomer and preliminary investigations into the solid phase peptide synthesis of PNA/DNA chimeras containing a neutral, internucleoside amide linkage are described.     

PNA的合成及其在基础医学中的应用

PNA是一类以多肽为骨架的核苷酸类似物,它不带电荷,杂交特异性强,能抵抗核酸酶及蛋白酶的降解,因此可作为杂交探针用于疾病诊断,或作为反义试剂进行基因治疗的探索。以下对PNA的合成及其在分子杂交诊断,基因治疗等基础医学领域的广泛用途做一综述。     

PNA的合成及在基础医学中的应用

PNA是一类以多肽为骨架的核苷酸类似物,它不带电荷,杂交特异性强,能抵抗核酸酶及蛋白酶的降解,因此可作为杂交探针用于疾病诊断,或作为反义试剂进行基因治疗的探索。以下对PNA的合成及其在分子杂交诊断、基因治疗等基础医学领域的广泛用途做一综述。     

γPNA一种新型高效的肽核酸

肽核酸(peptide nucleic acid,PNA)是一种人工合成的具有类多肽骨架的DNA类似物,具有与核酸结合特异性强、组织和细胞内生物稳定性好、半衰期长等优点。通过靶向结合DNA/RNA而抑制其复制、转录和翻译过程,进行基因调控。在PNA骨架结构中γ位点引入带手性的官能团,能形成右手螺旋结构,显著提高其与靶DNA/RNA的杂交特性,这种PNA衍生物称之为γPNA。γPNA的溶解性、热稳定性和特异性等化学与生物学特性明显改善,在基因编辑和作为探针检测等方面具有良好的应用前景。通过对γPNA结构、性质及其研究进展进行总结,以期为γPNA反义应用提供理论依据和参考。     

β-PNA: peptide nucleic acid (PNA) with a chiral center at the β-position of the PNA backbone

Peptide nucleic acid (PNA) monomers with a methyl group at the β-position have been synthesized. The modified monomers were incorporated into PNA oligomers using Fmoc chemistry for solid-phase synthesis. Thermal denaturation and circular dichroism (CD) studies have shown that PNA containing the S-form monomers was well suited to form a hybrid duplex with DNA, whose stability was comparable to that of unmodified PNA–DNA duplex, whereas PNA containing the R-form monomers was not.     

C3′-endo-puckered pyrrolidine containing PNA has favorable geometry for RNA binding: Novel ethano locked PNA (ethano-PNA)

A novel peptide nucleic acid (PNA) analogue is designed with a constraint in the aminoethyl segment of the aegPNA backbone so that the dihedral angle β is restricted within 60–80°, compatible to form PNA:RNA duplexes. The designed monomer is further functionalized with positively charged amino-/guanidino-groups. The appropriately protected monomers were synthesized and incorporated into aegPNA oligomers at predetermined positions and their binding abilities with cDNA and RNA were investigated. A single incorporation of the modified PNA monomer into a 12-mer PNA sequence resulted in stronger binding with complementary RNA over cDNA. No significant changes in the CD signatures of the derived duplexes of modified PNA with complementary RNA were observed.     

肽核酸(peptide nucleic acid,PNA)阵列

肽核酸(PNA)以N—(2—氨基乙基)甘氨酸替代DNA分子中的磷酸戊糖骨架。它能特异性地识别与DNA、RNA所形成的杂交体。PNA—DNA、PNA—RNA的热稳定性要比相应的DNA—DNA、DNA—RNA高,而且PNA识别单碱基的能力强于DNA和RNA,使之在微阵列,尤其是SNP检测领域有着广泛的应用前景。本文简述了PNA阵列从探针设计、阵列合成、杂交和检测的全过程。     

Fast and easy colorimetric tests for single mismatch recognition by PNA–DNA duplexes with the diethylthiadicarbocyanine dye and succinyl-β-cyclodextrin

The 3,3′-diethylthiacarbocyanine (DiSC₂(5)) dye is able to aggregate on full matched PNA–DNA duplexes by changing its absorption properties, which are manifested by an instantaneous colour shift from blue to purple. However the spontaneous aggregation of the dye also on mismatched duplexes and even on free PNA strands makes the test quite aspecific. Here it is demonstrated that the addition of succinyl-β-cyclodextrin (Succ-β-CyD) to the solutions containing PNA–DNA duplexes and the dye strongly enhances the specificity of the colour shift, allowing for a fast, very specific and extremely sensitive visual recognition of mismatches in DNA strands by using PNA probes in combination with the DiSC₂(5) dye. The phenomenon has been studied by CD and NMR spectroscopies. The method has been optimized and preliminarily applied for the recognition of an apoE gene mutation in human DNA samples.     

Binding citrate/DNA in presence of divalent cations – Potential mimicry of acidic peptides/DNA interactions

Citric acid whose structure is comparable to that of small acidic peptides, can bind to DNA in the presence of divalent cations (Cu²⁺, Fe²⁺, Zn²⁺, Mg²⁺). Citrate-DNA interaction occurs also in a cell homogenate and in this experimental model too requires the presence of natural divalent cations. In fact the addition of 2 mM EDTA to cell homogenate strongly decreases the DNA-citrate binding. The results demonstrate that divalent cations can act as bridges between two acidic molecules and that citric acid can mimic the structure of acidic peptides.     

DNA甲基化/去甲基化与疾病概览

DNA甲基化(5m C)状态与疾病的发生发展密切相关,异常甲基化状态是肿瘤的重要特征,包括基因组整体甲基化水平降低和Cp G岛局部甲基化程度的异常升高。近期研究还发现,DNA甲基化可以继续氧化为DNA羟甲基化(5hm C),而5hm C可能是一种新的表观修饰或者参与DNA去甲基化。随着DNA甲基化测序技术的发展,可以得到全基因组单碱基分辨率的5m C和5hm C图谱,深入研究5m C和5hm C的动态变化对发育和肿瘤的影响,并期望找到潜在应用于肿瘤诊断和治疗的表观标志物。该文主要总结了DNA甲基化/去甲基化及其在肿瘤发生发展过程中的动态变化、潜在的表观标志物以及检测和治疗研究进展。     

DNA剪刀——TALEN和CRISPR/Cas

对基因组中特定位点进行修饰的实验手段称为基因组编辑。它在研究基因的功能和基因修复以及细胞替代治疗上有广泛的应用前景。该文将回顾基因组编辑技术的最新进展和应用,着重介绍两种最新出现的序列特异核酸酶——TALEN和CRISPR／Cas在基因组编辑技术中的应用。     

丝氨酸/苏氨酸蛋白磷酸酶与DNA损伤应答

DNA损伤应答(DNA damage response,DDR)是维持基因组稳定性的核心机制,对DDR的研究不仅有助于阐明癌症发生发展的机理,同时也为癌症治疗和抗癌新药开发提供生物学基础。蛋白质翻译后修饰,尤其是蛋白激酶介导的磷酸化修饰和蛋白磷酸酶介导的去磷酸化修饰,参与调控绝大多数的生命活动过程,包括DDR。对蛋白激酶ATM/ATR/CHK2/CHK1介导的DDR的研究已经比较透彻,但是对蛋白磷酸酶在DDR中的功能研究还有待加强和深入。比较全面地综述丝氨酸/苏氨酸蛋白磷酸酶在DDR中的功能并探讨在抗癌新药开发中的前景。